RYE, N.Y., Aug.  12, 2026  (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare &amp; WellnessRx Trust (NYSE:GRX) (the &#34;Fund&#34;) declared a $0.17 per share cash distribution payable September 23,

Gabelli Healthcare & WellnessRx Trust Declares Third Quarter Distribution of $0.17 Per Share

Gabelli Healthcare & Wellness RX Trust declares $0.17 distribution for Sept 23

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>RYE, N.Y., Aug.  12, 2026  (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare &amp;amp; WellnessRx Trust (NYSE:GRX) (the &amp;#34;Fund&amp;#34;) declared a $0.17 per share cash distribution payable September 23,</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>GRX announced a $0.17 per-share cash distribution for September 23, 2026, with a record date of September 16. The board notes that distributions may include long-term capital gains or return of capital, and that the distribution policy can be modified or terminated. With $232 million in net assets and a tax-mix outlook, near-term price moves may hinge on ex-date dynamics and NAV/discount behavior.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>GRX declares $0.17 per-share distribution for Sep 23; record Sep 16.</li><li>Board reviews quarterly distributions; policy can change or end.</li><li>Distributions may include long-term capital gains or return of capital.</li><li>Net assets $232M; 2026 mix ~11% NII, 47% gains, 42% ROC.</li><li>Tax reporting: 1099-DIV in early 2027; tax treatment defined.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>The Gabelli Healthcare &amp; Wellness Rx Trust (GRX)</strong>: Subject of the distribution; ex-date and distribution details directly affect near-term price and income-investor demand.</li><li><strong>GAMCO Investors, Inc. (GAMI)</strong>: Fund manager; distribution policy oversight by Gabelli Funds, LLC; potential indirect impact on GRX&#039;s payout approach.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>Category: Corporate Developments. Routine distribution update with tax components; can create short-term NAV/discount moves for a closed-end fund like GRX.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Ex-div/record dates around Sept 16–23 may cause a temporary GRX price move.</li><li>GRX&#039;s $232M asset base implies modest liquidity; discount/premium shifts matter.</li><li>Tax mix (11% NII, 47% capital gains, 42% ROC) influences after-tax yield perception.</li><li>Board can modify or terminate the distribution policy; watch for commentary.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>$0.17 per share cash distribution payable September 23, 2026; record date September 16, 2026.</li><li>Total net assets: $232 million.</li><li>2026 distribution components: approx 11% net investment income, 47% net capital gains, 42% return of capital.</li><li>Long-term capital gains tax up to 20%; 3.8% NIIT for certain high-income shareholders.</li><li>Distributions may be recharacterized; 1099-DIV sent in early 2027.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Near-term neutral; ex-date and NAV-discount dynamics likely drive modest GRX price moves.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="justify">RYE, N.Y., Aug.  12, 2026  (GLOBE NEWSWIRE) -- The Board of Trustees of The Gabelli Healthcare &amp; Wellness<sup>Rx</sup> Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/GRX">GRX</a>) (the "Fund") declared a $0.17 per share cash distribution payable September 23, 2026 to common shareholders of record on September 16, 2026.</p>  <p align="justify">The Fund intends to pay a quarterly distribution of an amount determined each quarter by the Board of Trustees. In addition to the quarterly distributions, and in accordance with the minimum distribution requirements of the Internal Revenue Code for regulated investment companies, the Fund may pay an adjusting distribution in December which includes any additional income and net realized capital gains in excess of the quarterly distributions for that year.</p>  <p align="justify">Each quarter, the Board of Trustees reviews the amount of any potential distribution and the income, realized capital gain, or capital available. The Board of Trustees will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s net asset value and the current financial market environment. The Fund’s distribution policy is subject to modification or termination by the Board of Trustees at any time, and there can be no guarantee that the policy will continue. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.</p>  <p align="justify">All or part of the distribution may be treated as long-term capital gain or qualified dividend income (or a combination of both) for individuals, each subject up to the maximum federal income tax rate for long term capital gains, which is currently 20% in taxable accounts for individuals (or less depending on an individual’s tax bracket). In addition, certain U.S. shareholders who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare surcharge on their &#34;net investment income&#34;, which includes dividends received from the Fund and capital gains from the sale or other disposition of shares of the Fund.</p>  <p align="justify">If the Fund does not generate sufficient earnings (dividends and interest income, less expenses, and realized net capital gain) equal to or in excess of the aggregate distributions paid by the Fund in a given year, then the amount distributed in excess of the Fund’s earnings would be deemed a return of capital. Since this would be considered a return of a portion of a shareholder’s original investment, it is generally not taxable and would be treated as a reduction in the shareholder’s cost basis.</p>  <p align="justify">Long-term capital gains, qualified dividend income, investment company taxable income, and return of capital, if any, will be allocated on a pro-rata basis to all distributions to common shareholders for the year. Based on the accounting records of the Fund currently available, each of the distributions paid to common shareholders in 2026 would include approximately 11% from net investment income, 47% from net capital gains and 42% would be deemed a return of capital on a book basis. This does not represent information for tax reporting purposes. The estimated components of each distribution are updated and provided to shareholders of record in a notice accompanying the distribution and are available on our website (www.gabelli.com). The final determination of the sources of all distributions in 2026 will be made after year end and can vary from the quarterly estimates. Shareholders should not draw any conclusions about the Fund’s investment performance from the amount of the current distribution. All individual shareholders with taxable accounts will receive written notification regarding the components and tax treatment for all 2026 distributions in early 2027 via Form 1099-DIV.</p>  <p align="justify"><em>Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. For more information regarding the Fund’s distribution policy and other information about the Fund, call:</em></p>  <p align="justify"><em>Bethany Uhlein</em><br></br><em>(914) 921-5546</em></p>  <p align="left"><strong>About The Gabelli Healthcare &amp; Wellness</strong><sup><strong>Rx</strong></sup><strong> Trust</strong><br></br>The Gabelli Healthcare &amp; Wellness<sup>Rx</sup> Trust is a diversified, closed-end management investment company with $232 million in total net assets whose primary investment objective is long-term growth of capital. The Fund is managed by Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc. (OTCQX:<a class="ticker" href="https://www.benzinga.com/quote/GAMI">GAMI</a>).</p>  <p align="left">NYSE: GRX<br></br>CUSIP – 36246K103</p>  <p>Investor Relations Contact: <br></br>Bethany Uhlein<br></br>914.921.5546<br></br>buhlein@gabelli.com</p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTgwODY5NiM3NzcyNzY4IzIyNTkwNzM="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/MTY0ODE2MzctYWMxYS00YTZkLWI1NzMtNmI1NjZiZDIyODExLTEyNzA2MjMtMjAyNi0wOC0xMi1lbg==/tiny/The-Gabelli-Healthcare-Wellnes.png" referrerpolicy="no-referrer-when-downgrade"></img><p><a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/518ebb08-69ce-410a-8fe1-07b9afaddb77"><img src="https://ml.globenewswire.com/media/518ebb08-69ce-410a-8fe1-07b9afaddb77/small/gabelli-funds-hor-positive-cmyk-jpg.jpg" border="0" width="150" height="40" alt="Primary Logo"></img></a></p>

GRX announced a $0.17 per-share cash distribution for September 23, 2026, with a record date of September 16. The board notes that distributions may include long-term capital gains or return of capital, and that the distribution policy can be modified or terminated. With $232 million in net assets and a tax-mix outlook, near-term price moves may hinge on ex-date dynamics and NAV/discount behavior.

News insight

Gabelli Healthcare & WellnessRx Trust Declares Third Quarter Distribution of $0.17 Per Share

AI summary

Sentiment rationale

Key facts

Corporate Developments